Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04715815
Other study ID # REC.63-359-8-1
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date February 2021
Est. completion date June 2022

Study information

Verified date January 2021
Source Prince of Songkla University
Contact Sasikaan Nimmaanrat, MD
Phone +66887907842
Email snimmaanrat@yahoo.com.au
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Many factors can affect pain and its severity. This study aims to explore how the COVID-19 affects chronic pain patients in terms of pain in general, intensity of pain, desire for pain treatment including follow up visits and pain medication refills as well as sleep.


Description:

Research question What are the effects of the COVID-19 on chronic pain patients in terms of pain and pain management? Conceptual framework The COVID-19 is a novel emerging infectious disease which has unimaginable and unbelievable large scale distressing effects worldwide. Up to date, there is no study which aims to evaluate the effects of the COVID-19 on chronic pain patients in terms of pain and pain management. The previous survey in patients focused on the worrisome of them for getting this infection and their confidence in their government to control the COVID-19 situation in the US. Materials and methods This study is an in-depth interview. The in-depth interview is the principal method to collect qualitative data by setting up open-ended questions beforehand. Patients who are interviewed, can express their attitudes freely. This method is flexible which words, sentences and questions can be adjusted to suit each interviewee (participant). The process consists of active and intentional listening as well as ask on an in-depth basis. All conversations during the in-depth interview are tape-recorded.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date June 2022
Est. primary completion date December 2021
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with chronic pain who have been under the health care service of the pain clinic of Songklanagarind hospital. - Chronic pain patients are patients with persistent pain for at least 3 months. Pain can be from any etiologies. - The expected number of interviwees for this in-depth interview is 30 or until the gathered interview data are saturated. Exclusion Criteria: - Patients who are not willing to participate this study and have time for an in person 'in-depth interview'. - Patients who are not influence in Thai language. - Patients who are physically or mentally too ill to participate this study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention (only interview)
Interview

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Prince of Songkla University

References & Publications (1)

Wolf MS, Serper M, Opsasnick L, O'Conor RM, Curtis L, Benavente JY, Wismer G, Batio S, Eifler M, Zheng P, Russell A, Arvanitis M, Ladner D, Kwasny M, Persell SD, Rowe T, Linder JA, Bailey SC. Awareness, Attitudes, and Actions Related to COVID-19 Among Adu — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary To explain how the COVID-19 affects chronic pain patients in terms of pain and pain management. An in-depth interview will be conducted to find out how the COVID-19 affects chronic pain patients. The investigators will measure pain intensity and sleep disturbance level by using an 11-point numerical rating scale where 0 means that the patient's pain condition is not affected by the COVID-19 and 10 means that the patient's pain condition is maximally affected. The higher the score is the worse. January to December 2021
Secondary To explain how the COVID-19 affects chronic pain patients' psychological status. An in-depth interview will be performed to find out how the COVID-19 affects the psychological aspect of chronic pain patients. The level of anxiety and stress will be measured using the 11-point verbal numerical rating scale where 0 means that the patient's psychological status is not affected by the COVID-19 and 10 means that the patient's psychological status is maximally affected. The higher the score is the worse. January to December 2021
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain